Marrongelli selected for her expertise in Botanical Drug Development LONDON, 15-Jun-2018 — /EuropaWire/ — As a leading expert in her field, Dr. Christina Marrongelli, PharmD has been chosen by the World Congress on Pharmacology & Chemistry of Natural Compounds to … Read the full press release
Posted in France, Government, Healthcare, News, Pharma & Biotech, Science, United Kingdom
Tagged biomedical sciences, Botanical Drug Development, botanical drugs, botanical medicines, botanicals, crofelemer, Dr. Christina Marrongelli, drug development, drug discovery, FD&C Act, herbal drug market, herbal medicines, heterogeneous botanical drug products, Maryland Board of Physicians, Medical University of South Carolina, medicine, Mytesi, natural compounds, Naturopathic Doctors Formulary Council, pharmaceutical market, pharmaceutical marketing, pharmacognosy, Pharmacology, PharmD, research and development, sinecatechins, The pharmaceutical industry, United States, Veregen®, World Congress on Pharmacology & Chemistry of Natural Compounds
NOTTINGHAM, 21-May-2018 — /EuropaWire/ — Researchers have discovered new natural compounds in a fig plant species native to Malaysia that could lead to improved treatment for resistant hypertension. Dr Kuan Hon Lim and his team from the University of Nottingham Malaysia have isolated a new class of natural compounds from a local fig plant species that induce vasodilation in aorta tissue, … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged aorta blood vessels, chromatography techniques, Dr Kuan Hon Lim, fig plant, High blood pressure, hypertension, natural compounds, resistant hypertension, treatment for resistant hypertension, University of Nottingham Malaysia, vasodilation
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?